Optimizing treatment selection and sequencing decisions for first-line maintenance therapy of newly diagnosed advanced ovarian cancer - International considerations amongst upper middle- and high-income countries (UMIC and HIC)

• Main Authors: Jeffrey C.H. Goh (Author), Charlie Gourley (Author), David S P Tan (Author), Angélica Nogueira-Rodrigues (Author), Hesham Elghazaly (Author), Marc Edy Pierre (Author), Gonzalo Giornelli (Author), Byoung-Gie Kim (Author), Flavia Morales-Vasquez (Author), Alexandra Tyulyandina (Author)
• Format: Book
• Published: Elsevier, 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The incidence and mortality rates of ovarian cancer are increasing globally. Ovarian cancer is diagnosed at an advanced stage in 80% of women. After standard, platinum-based, front-line chemotherapy, poly (ADP-ribose) polymerase (PARP) inhibitors and antiangiogenic agents are successfully employed a...